The Earnings Metrics That Matter Most, by Sector

EPS and revenue get all the headlines. But the metrics that actually move stocks after earnings are often sector-specific numbers buried deeper in the report. A 10% EPS beat means nothing if cloud ARR decelerated. A revenue miss is forgiven if same-store sales accelerated.

We analyzed post-earnings price reactions across 29,000+ reports to identify which metrics correlate most strongly with stock moves in each sector. The results vary dramatically.

Technology

Tech is a growth story. The market rewards acceleration and punishes deceleration, even when absolute numbers look strong.

• Revenue growth rate (YoY) — The single most watched metric. A company growing 35% YoY that slows to 28% will get punished, even if it "beat" estimates. We found that tech stocks where YoY revenue growth accelerated quarter-over-quarter posted average 1-week returns of +4.2% after earnings. Decelerating growth averaged -2.1%.
• Cloud/subscription ARR — For SaaS companies, annual recurring revenue growth is the forward indicator. Wall Street models future revenue from ARR, so a miss here reprices the entire model.
• AI-specific revenue — Since 2024, any company reporting an "AI segment" faces intense scrutiny on its growth rate. Vague references to "AI tailwinds" without specific revenue numbers get discounted.

Secondary metrics: gross margin trend, net retention rate, free cash flow margin. Profitability matters more now than it did in 2021, but growth is still king in tech.

Financials

Banks trade on spread income and credit quality. The earnings headline is almost irrelevant compared to these three numbers.

• Net interest income (NII) — The difference between what banks earn on loans and pay on deposits. NII drives 50-70% of revenue for most banks. A 3% NII miss can tank a stock even if overall EPS beats. In rising rate environments, NII expansion is expected. Falling short of that expectation is penalized heavily.
• Loan loss provisions — How much the bank sets aside for expected defaults. Rising provisions signal that management sees credit quality deteriorating. This is the forward-looking fear metric. When JPMorgan's provisions jumped 38% in Q3 2025, the stock dropped 4% despite an EPS beat.
• Trading revenue — For the large investment banks (GS, MS, JPM), trading desk results are volatile and often determine the beat/miss. A strong trading quarter can mask weakness elsewhere.

Secondary metrics: efficiency ratio, book value growth, capital ratios (CET1).

Consumer Discretionary

Consumer stocks are a proxy for the economy. The metrics that matter are about demand, not efficiency.

• Same-store sales (comps) — Growth from existing locations, stripping out new store openings. For retailers and restaurants, this is the metric. A retailer can beat EPS through cost cuts, but if comps are negative, the stock drops. We found that consumer stocks with positive comps outperformed those with negative comps by an average of 6.8% in the month after earnings, regardless of the EPS headline.
• Inventory levels — Rising inventory relative to sales signals future markdowns and margin pressure. Inventory-to-sales ratio creeping up is an early warning. Target's inventory buildup in 2022 presaged quarters of margin compression.
• Consumer confidence signals — Management commentary about foot traffic, average transaction size, and customer acquisition costs. These qualitative signals from the earnings call often drive the reaction more than the numbers.

Healthcare

Healthcare splits into two categories: pharma/biotech (pipeline-driven) and medical devices/services (more traditional). The metrics that matter differ significantly.

• Pipeline data and drug approvals — For biotech, a single FDA decision overshadows 10 quarters of earnings. Phase 3 trial results, approval timelines, and regulatory setbacks drive price action. Revenue and EPS are secondary to the pipeline narrative.
• Revenue by drug/product — For large pharma, watch the revenue trajectory of key drugs, especially those facing patent cliffs. Humira's biosimilar competition reshaped AbbVie's earnings story entirely. Investors want to see replacement revenue growing faster than legacy revenue declining.
• R&D spending as % of revenue — Higher R&D spend is tolerated if the pipeline justifies it. But if R&D is rising and the pipeline is thinning, that's a red flag. Context matters more than the absolute number.

Energy

Energy companies are price-takers. Their earnings are largely determined by commodity prices, so the metrics that differentiate good operators from bad ones are about efficiency and discipline.

• Production volumes — Barrels of oil equivalent per day (BOE/d). Are they growing production, maintaining, or declining? Production growth in a stable price environment means revenue growth. Production declines, even with higher commodity prices, signal field depletion or capital discipline.
• Breakeven price — The oil or gas price at which the company covers all costs. Lower breakeven = more resilient in downturns. Companies with breakevens below $40/barrel are positioned very differently than those at $60.
• Capital return policy — Dividends, buybacks, and debt reduction. After years of over-investment that destroyed returns, the market now rewards energy companies that return cash to shareholders. A raised dividend or expanded buyback often matters more than the production numbers.

Quick Reference Table

How to Apply This

Before an earnings report, identify the sector-specific metrics that matter. Check the company's earnings history on BigEarnings, then read the actual press release looking for these numbers specifically.

1. Search any ticker on BigEarnings to see its sector context and fundamental breakdown
2. Check the sector beat rate on the Performance Dashboard to see whether the whole sector is outperforming or struggling
3. Read the quarterly preview for macro context on what the market is watching this season

Start free to track sector-specific earnings data across 6,200+ companies.